Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127097821 | 12709782 | 1 | I | 201608 | 20160825 | 20160901 | 20160901 | EXP | US-009507513-1608USA013732 | MERCK | 60.00 | YR | F | Y | 0.00000 | 20160901 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127097821 | 12709782 | 1 | PS | PRINIVIL | LISINOPRIL | 1 | Oral | 10 MG, TWICE DAILY | 60 | MG | 19558 | 10 | MG | TABLET | BID | ||||
| 127097821 | 12709782 | 2 | SS | PRINIVIL | LISINOPRIL | 1 | Oral | 10 MG | 60 | MG | 19558 | 10 | MG | TABLET | |||||
| 127097821 | 12709782 | 3 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | 25 MICROGRAM, ONCE DAILY | 0 | 25 | UG | TABLET | QD | |||||||
| 127097821 | 12709782 | 4 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 10 MEQ, 3 TABLETS TWICE DAILY | 0 | 3 | DF | TABLET | BID | |||||||
| 127097821 | 12709782 | 5 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | 50MG, TWICE DAILY | 0 | 50 | MG | TABLET | BID | |||||||
| 127097821 | 12709782 | 6 | C | HYDROXYZINE PAMOATE. | HYDROXYZINE PAMOATE | 1 | 50MG, TWICE DAILY | 0 | 50 | MG | CAPSULE | BID | |||||||
| 127097821 | 12709782 | 7 | C | LASIX | FUROSEMIDE | 1 | 40 MG, TWICE DAILY | 0 | 40 | MG | BID | ||||||||
| 127097821 | 12709782 | 8 | C | CYCLOBENZAPRINE HYDROCHLORIDE. | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | 30 MG (3 TABLETS), TWO AT NIGHT AND ONE IN THE MORNING | 0 | 30 | MG | TABLET | TID | |||||||
| 127097821 | 12709782 | 9 | C | PRAZOSIN | PRAZOSIN | 1 | 2MG, TWICE DAILY | 0 | 2 | MG | BID | ||||||||
| 127097821 | 12709782 | 10 | C | LYRICA | PREGABALIN | 1 | 225MG, TWICE DAILY | 0 | 225 | MG | CAPSULE | BID | |||||||
| 127097821 | 12709782 | 11 | C | GLYBURIDE. | GLYBURIDE | 1 | 2.5MG, TWICE DAILY | 0 | 2.5 | MG | TABLET | BID | |||||||
| 127097821 | 12709782 | 12 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 1000MG, TWICE DAILY | 0 | 1000 | MG | TABLET | BID | |||||||
| 127097821 | 12709782 | 13 | C | LORAZEPAM. | LORAZEPAM | 1 | 2 MG TABLET, WHEN NEEDED FOR MOVEMENT | 0 | TABLET | ||||||||||
| 127097821 | 12709782 | 14 | C | ESCITALOPRAM | ESCITALOPRAM OXALATE | 1 | 20 MG, TWICE DAILY | 0 | 20 | MG | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127097821 | 12709782 | 1 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127097821 | 12709782 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127097821 | 12709782 | Abdominal pain upper | |
| 127097821 | 12709782 | Diarrhoea | |
| 127097821 | 12709782 | Dizziness | |
| 127097821 | 12709782 | Dyspnoea | |
| 127097821 | 12709782 | Dysstasia | |
| 127097821 | 12709782 | Eructation | |
| 127097821 | 12709782 | Eye movement disorder | |
| 127097821 | 12709782 | Flatulence | |
| 127097821 | 12709782 | Gait disturbance | |
| 127097821 | 12709782 | Hypertensive crisis | |
| 127097821 | 12709782 | Movement disorder | |
| 127097821 | 12709782 | Nausea | |
| 127097821 | 12709782 | Pain | |
| 127097821 | 12709782 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127097821 | 12709782 | 1 | 20160818 | 20160820 | 0 | |
| 127097821 | 12709782 | 2 | 20160825 | 0 |